Kailera Therapeutics, Inc. KLRA

Set alert

Price alert · KLRA

All alert types
12.54 USD +0.39 +3.21%

As of Nov 3, 2:49 PM ET

Bid
12.50 × 2
Ask
12.56 × 2
12.30 Day range 13.03
9.76 52-week range 28.23
YTD
-51.77%
1 year
-51.77%
Open
12.32
Prev close
12.15
Mkt cap
1.62B
Vol
374.37K
Avg vol
1.04M
EPS
-4.51
P/E
0.00
Div yield
0.00%
More statistics
Low
12.30
High
13.03
Forward P/E
-2.83
Beta
0.00
Short ratio
5.58
Inst. own
90.55%
Dividend
0.00
Ex-div date
Earnings
Dec 2, 2026
50-d avg
13.29
200-d avg
17.98
1y target
42.75

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for KLRA has not been loaded yet. Try again in a moment.

Analyst view

Price target (mean) 42.75 +240.9% upside
Target (low)
30.00
Target (mean)
42.75
Target (high)
57.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 6
  • 2 months ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

KLRA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-1.01-1.30 – -0.790.000.0%00.0%5
Next quarter-1.16-1.54 – -0.950.000.0%00.0%5
Current year-4.10-5.86 – -2.960.000.0%00.0%5
Next year-4.30-5.89 – -2.99-4.10-4.9%00.0%5

Upgrades and downgrades

The latest rating changes

KLRA analyst upgrades and downgrades
DateFirmActionFromTo
May 12, 2026Leerink PartnersInitiated—Outperform
May 12, 2026JefferiesInitiated—Buy
May 12, 2026Evercore ISI GroupInitiated—Outperform
May 12, 2026JP MorganInitiated—Overweight